Charles Schwab’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,278
| Closed | -$50.7K | – | 3510 |
|
|
2024
Q3 | $50.7K | Hold |
13,278
| – | – | ﹤0.01% | 3413 |
|
|
2024
Q2 | $38.9K | Sell |
13,278
-63,925
| -83% | -$187K | ﹤0.01% | 3537 |
|
|
2024
Q1 | $306K | Hold |
77,203
| – | – | ﹤0.01% | 3170 |
|
|
2023
Q4 | $384K | Hold |
77,203
| – | – | ﹤0.01% | 3167 |
|
|
2023
Q3 | $390K | Hold |
77,203
| – | – | ﹤0.01% | 3135 |
|
|
2023
Q2 | $388K | Buy |
77,203
+63,925
| +481% | +$322K | ﹤0.01% | 3163 |
|
|
2023
Q1 | $81.7K | Hold |
13,278
| – | – | ﹤0.01% | 3279 |
|
|
2022
Q4 | $175K | Buy |
+13,278
| New | +$175K | ﹤0.01% | 3197 |
|
|
2018
Q2 | – | Sell |
-4,475
| Closed | -$106K | – | 3139 |
|
|
2018
Q1 | $106K | Sell |
4,475
-5
| -0.1% | -$118 | ﹤0.01% | 3034 |
|
|
2017
Q4 | $840K | Buy |
4,480
+471
| +12% | +$88.3K | ﹤0.01% | 2566 |
|
|
2017
Q3 | $861K | Buy |
4,009
+245
| +7% | +$52.6K | ﹤0.01% | 2543 |
|
|
2017
Q2 | $773K | Buy |
3,764
+27
| +0.7% | +$5.55K | ﹤0.01% | 2547 |
|
|
2017
Q1 | $681K | Buy |
3,737
+239
| +7% | +$43.6K | ﹤0.01% | 2543 |
|
|
2016
Q4 | $875K | Buy |
3,498
+216
| +7% | +$54K | ﹤0.01% | 2473 |
|
|
2016
Q3 | $684K | Buy |
3,282
+1,296
| +65% | +$270K | ﹤0.01% | 2512 |
|
|
2016
Q2 | $402K | Buy |
1,986
+669
| +51% | +$135K | ﹤0.01% | 2668 |
|
|
2016
Q1 | $242K | Buy |
1,317
+23
| +2% | +$4.23K | ﹤0.01% | 2836 |
|
|
2015
Q4 | $324K | Buy |
+1,294
| New | +$324K | ﹤0.01% | 2834 |
|